NuGen Medical DevicesNGMDF EV-to-FCF is -4.95 as of Jun. 25, 2026. The stock has 7 warning signs investors should review. Among 418 Medical Devices & Instruments companies, NuGen Medical Devices ranks worse than 239234.21% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, NuGen Medical Devices's Enterprise Value is $14.57 Mil.
NuGen Medical Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.94 Mil. Therefore, NuGen Medical Devices's EV-to-FCF for today is -4.95.
The historical rank and industry rank for NuGen Medical Devices's EV-to-FCF or its related term are showing as below:
NGMDF'
s EV-to-FCF Range Over the Past 10 Years
Min: -22.01 Med: -5.27 Max: -2.11
Current: -5.09
During the past 6 years, the highest EV-to-FCF of NuGen Medical Devices was -2.11. The lowest was -22.01. And the median was -5.27.
NGMDF's EV-to-FCF is ranked worse than 100% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.66
vs NGMDF: -5.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NuGen Medical Devices (OTCPK:NGMDF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NuGen Medical Devices's PE Ratio (TTM) for today is calculated as:
NuGen Medical Devices's share price for today is $0.01565.
NuGen Medical Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.043.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, NuGen Medical Devices's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NuGen Medical Devices EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where NuGen Medical Devices's EV-to-FCF falls into.
NuGen Medical Devices's current Enterprise Value is $14.57 Mil.
NuGen Medical Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NuGen Medical Devices (NGMDF) has a EV-to-FCF of -4.95 as of Jun. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on NuGen Medical Devices and its competitors. According to the industry distribution chart, NuGen Medical Devices ranks #999999 out of 418 companies in the Medical Devices & Instruments industry.
Is NuGen Medical Devices' EV-to-FCF too high?
NuGen Medical Devices' current EV-to-FCF is -4.95. Based on the distribution chart, NuGen Medical Devices ranks #999999 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does NuGen Medical Devices' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NuGen Medical Devices ranks #999999 out of 418 companies for EV-to-FCF. This places NuGen Medical Devices in the lower half of its industry. The industry median EV-to-FCF is 22.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.66, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on NuGen Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NuGen Medical Devices's current EV-to-FCF is -4.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current EV-to-FCF is -4.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current EV-to-FCF is -4.95 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGMDF has been successfully added to your 